NasdaqGM:FUTU
NasdaqGM:FUTUCapital Markets

Assessing Futu Holdings (NasdaqGM:FUTU) Valuation After Moomoo’s Role In BitGo’s Landmark Crypto IPO

Moomoo’s role in BitGo’s crypto IPO and why it matters for Futu Holdings (NasdaqGM:FUTU) Futu Holdings (NasdaqGM:FUTU) is back in focus after its moomoo platform enabled expanded retail participation in BitGo’s Initial Public Offering, the first crypto IPO of 2026, capturing just under 10% of the total offering. See our latest analysis for Futu Holdings. While the BitGo IPO has put moomoo and Futu back in the headlines, the recent share price performance tells a more mixed story. The 7 day...
NYSE:CMA
NYSE:CMABanks

Comerica Merger Approvals Set Stage For Larger Bank And Valuation Questions

Comerica (NYSE:CMA) and Fifth Third Bancorp have secured all required regulatory and shareholder approvals for their merger. The combined company is expected to close the transaction on February 1, 2026, forming one of the largest U.S. banks. The deal is set to reshape Comerica's business profile, customer footprint, and role in the U.S. banking sector. For you as an investor, this puts Comerica at the center of one of the bigger U.S. bank combinations currently in the works. Comerica has...
NYSE:AXS
NYSE:AXSInsurance

A Look At AXIS Capital Holdings (AXS) Valuation After New AI Cyber Risk And Budget Survey Release

AXIS Capital Holdings (AXS) is back on investors’ radar after releasing a survey of 500 CEOs and CISOs that puts AI driven cyber attacks and rising cybersecurity budgets firmly in the spotlight. See our latest analysis for AXIS Capital Holdings. The AI cyber risk survey lands at a time when AXIS Capital Holdings’ share price is US$102.07, with a 90 day share price return of 11.89% and a 1 year total shareholder return of 17.80%. The 5 year total shareholder return of 155.47% points to strong...
NasdaqGS:ZBRA
NasdaqGS:ZBRAElectronic

Is Zebra Technologies (ZBRA) Now Attractive After A 42% One-Year Share Price Slump?

If you are wondering whether Zebra Technologies at around US$240.54 is a potential bargain or a value trap, you are not alone. The answer depends on how you look at its valuation. The share price has seen a 4.2% decline over the last 7 days, a 2.3% decline over the last 30 days, a 3.1% decline year to date, and a 42.0% decline over the last year, with a 24.1% decline over 3 years and a 38.0% decline over 5 years, which may have changed how investors view both its upside and its risks. These...
NYSE:MCK
NYSE:MCKHealthcare

Is It Too Late To Consider McKesson (MCK) After Its Strong Multi‑Year Run?

If you are wondering whether McKesson at around US$820 a share is still reasonably priced or starting to look expensive, you are in the right place. The stock has eased back recently, with a 2.4% decline over the last week and a 0.8% decline over the last month, although the 1 year return sits at 39.2% and the 3 year return at 119.5%. Recent coverage has focused on McKesson as one of the large distributors at the heart of the U.S. healthcare supply chain. This keeps it in the spotlight...
NasdaqGS:AUR
NasdaqGS:AURSoftware

Aurora Innovation (AUR) Valuation Check As McLeod Integration Begins Delivering Autonomous Trucking Benefits

Aurora Innovation (AUR) is back in focus after completing an API integration with McLeod Software that lets eligible trucking customers book and manage autonomous loads directly inside existing transportation management workflows. See our latest analysis for Aurora Innovation. The McLeod integration and upcoming fourth quarter 2025 update come at a time when Aurora Innovation’s share price is US$4.58, with a year to date share price return of 18.35% but a 1 year total shareholder return...
NasdaqGS:CAKE
NasdaqGS:CAKEHospitality

Is It Too Late To Consider Cheesecake Factory (CAKE) After Strong Share Price Gains?

If you have been eyeing Cheesecake Factory and wondering whether the current share price offers fair value or a potential opportunity, this breakdown is for you. The stock last closed at US$58.88, with returns of 14.0% over 30 days, 11.5% year to date, 16.8% over 1 year, 64.8% over 3 years and 45.4% over 5 years, which naturally raises questions about what is now priced in. Recent attention on Cheesecake Factory has centered on how the business is managing costs, traffic trends and its...
NasdaqGS:ARQT
NasdaqGS:ARQTBiotechs

Patient Survey on Steroid Concerns Could Be A Game Changer For Arcutis Biotherapeutics (ARQT)

In January 2026, Arcutis Biotherapeutics released results from its nationwide Skin Insights survey, revealing how adults and parents of children with plaque psoriasis, atopic dermatitis, and seborrheic dermatitis view topical steroid use and disease management. The findings point to a widespread reliance on reactive, flare-focused care and high concern about steroid side effects, highlighting interest in longer-term, non-steroidal treatment approaches. We’ll now examine how this emphasis on...
NYSE:COHR
NYSE:COHRElectronic

Assessing Coherent (COHR) Valuation After New Photonics And Quantum Product Launches

Coherent (COHR) is back in focus after a flurry of product launches, including its Bondable Diamond thermal management platform, a germanium free electro optic modulator, and AxioView imaging fibers for medical systems. See our latest analysis for Coherent. Those product launches have arrived as interest in Coherent has picked up, with the share price at US$196.94 after a 52% 90 day share price return and a very large 3 year total shareholder return of 336%. This suggests that momentum has...
NYSE:MCO
NYSE:MCOCapital Markets

Is It Too Late To Consider Moody's (MCO) After Its Strong Multi Year Share Price Run

If you are wondering whether Moody's current share price still makes sense after a strong multi year run, this article will walk through what that price might imply about the company. Moody's closed at US$524.04, with a 2.8% decline over the last 7 days, a 1.3% gain over 30 days, a 5.0% gain year to date, a 7.8% gain over 1 year, a 68.1% gain over 3 years and a 105.2% gain over 5 years. Recent moves in the stock sit against an ongoing demand backdrop for credit ratings and analytics, as...
NYSE:CFG
NYSE:CFGBanks

The Bull Case For Citizens Financial Group (CFG) Could Change Following Earnings Beat And Capital Return Moves

In January 2026, Citizens Financial Group reported strong fourth-quarter and full-year 2025 results, including higher net interest income of US$1,537 million for the quarter and net income of US$528 million, alongside a quarterly dividend of US$0.46 per share and completion of a US$400 million subordinated note offering. Beyond the headline earnings beat, the bank’s private banking franchise and reduction of non-core assets contributed meaningfully to profitability while capital returns...
NYSE:SEE
NYSE:SEEPackaging

Assessing Sealed Air (SEE) Valuation After Recent Share Price Rebound And Cash Flow Outlook

Why Sealed Air Stock Is On Investor Radars Today Sealed Air (SEE) is back in focus after recent trading, with the packaging company drawing attention for its current valuation metrics and mixed return profile across the past year and past 3 months. See our latest analysis for Sealed Air. At a share price of $41.79, Sealed Air has seen a 19.91% 90 day share price return, while its 1 year total shareholder return of 20.74% contrasts with a weaker 3 year total shareholder return of 16.57%. If...
NYSE:TDOC
NYSE:TDOCHealthcare Services

Teladoc’s Data-Driven 24/7 Care Upgrade Could Be A Game Changer For Teladoc Health (TDOC)

Earlier this month, Teladoc Health launched nationwide enhancements to its 24/7 Care virtual urgent care service, expanding treatable conditions, integrating specialist consults, preventive-care prompts, in-network referrals, and real-time prescription benefit checks through its Prism care delivery platform. An interesting aspect of this update is how Teladoc Health is using integrated claims and health information data to trigger preventive-care actions during urgent visits, aiming to move...
NasdaqGS:GTLB
NasdaqGS:GTLBSoftware

GitLab (GTLB) Valuation Check As Analyst Concerns Meet New AI Duo Agent Platform

GitLab (GTLB) is back in focus after analyst commentary highlighted slowing revenue growth, high valuation concerns, and weaker customer retention, just as the company pushes its AI ambitions with the new Duo Agent Platform. See our latest analysis for GitLab. GitLab's latest AI push and recent CTO change come against a choppy share performance, with a 6.56% 7 day share price return, a 25.04% 90 day share price decline, and a 43.85% 1 year total shareholder return decline, indicating fading...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

A Look At MicroVision (MVIS) Valuation After Nasdaq Minimum Bid Price Deficiency Notice

Nasdaq deficiency notice puts focus on MicroVision’s listing status MicroVision (MVIS) recently received a deficiency notice from Nasdaq after its shares traded below the US$1 minimum bid price requirement for roughly a month. This has prompted fresh questions around its listing status. See our latest analysis for MicroVision. The deficiency notice comes after a weak run for MicroVision, with a 90 day share price return of 29.07% and a 1 year total shareholder return of 50.51%, pointing to...
NasdaqGM:HROW
NasdaqGM:HROWPharmaceuticals

Is Harrow (HROW) Share Weakness Creating A Long Term Opportunity For Investors

If you are asking yourself whether Harrow is still reasonably priced after its run in recent years, this breakdown will help you connect the current share price with what the underlying numbers suggest about value. The stock has pulled back recently, with a 7.2% decline over the last week, 11.3% over the past month, and a 10.9% fall year to date, even though the 1 year return sits at 33.3% and the 3 year return is 201.9%. That mix of shorter term weakness and longer term strength raises an...
NYSE:HP
NYSE:HPEnergy Services

A Look At Helmerich & Payne (HP) Valuation After CEO Transition And KCA Deutag Integration News

Helmerich & Payne (HP) has put leadership and governance in focus by announcing CEO John W. Lindsay’s planned retirement after the March 4, 2026 virtual annual meeting and naming President Raymond John “Trey” Adams III as his successor. See our latest analysis for Helmerich & Payne. At a share price of US$32.30, Helmerich & Payne has recently seen short term momentum pick up, with a 30 day share price return of 15.44% and a 90 day gain of 25.97%. However, the 1 year total shareholder return...
NYSE:MDT
NYSE:MDTMedical Equipment

Medtronic Advances Cardiology And Diabetes Portfolio With New Approvals And Investment

Medtronic (NYSE:MDT) has made a substantial investment in Anteris Technologies to support next generation heart valve development and potential future collaborations. The company secured European regulatory approval and completed initial U.S. clinical cases for its Affera Sphere-360 all in one mapping and pulsed field ablation catheter in atrial fibrillation care. Medtronic also received FDA clearance for its MiniMed Go diabetes management system, which integrates multiple smart technologies...
NasdaqGS:CDNS
NasdaqGS:CDNSSoftware

Cadence HiFi iQ DSP Launch Highlights Growth Potential And Valuation Risks

Cadence Design Systems (NasdaqGS:CDNS) has introduced its sixth-generation Tensilica HiFi iQ DSP architecture. The new DSP targets next-generation voice AI and immersive audio use cases in devices such as home entertainment systems, automobiles, and smartphones. The architecture is designed to increase compute and AI performance while improving energy efficiency and supporting advanced audio codecs. Cadence Design Systems, known for its electronic design automation tools and IP, is...
NasdaqGS:WIX
NasdaqGS:WIXIT

Wix Harmony Launch And Super Bowl Push Reframe Growth Prospects

Wix.com (NasdaqGS:WIX) has launched Wix Harmony, an AI website builder that combines natural language inputs with visual editing tools. The product is designed to support both individuals and businesses, using Wix's existing infrastructure to handle more advanced and scalable website needs. Wix is backing the launch with a major marketing push, including a new Super Bowl TV commercial aimed at broadening brand awareness. Wix.com enters this product launch with its shares trading at $88.48...
NYSE:KLAR
NYSE:KLARDiversified Financial

Does Klarna Group (KLAR) Still Justify Its Valuation After Recent Share Price Pullback?

Some investors may be wondering whether Klarna Group at US$27.70 is starting to look interesting, or whether the market is still working out what it is worth. The stock has recently pulled back, with a 4.5% decline over the last 7 days, an 8.9% decline over 30 days and a 3.0% decline year to date, which may signal shifting views on its growth potential and risk. These moves come as Klarna Group continues to attract attention as a listed fintech name, with ongoing discussion around its...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

Is It Time To Revisit Interparfums (IPAR) After Mixed Recent Share Price Swings?

If you are wondering whether Interparfums at around US$98.76 is attractively priced or asking too much for its brand power, you are in the right place. The stock has recently shown sharp moves, with returns of 9.8% over 7 days and 15.8% over 30 days. It also carries a 27.8% decline over 1 year and a 6.1% decline over 3 years, alongside a 77.3% gain over 5 years. These mixed returns come against a backdrop of ongoing attention on branded fragrance and beauty companies, where investors have...
NasdaqGS:SHOP
NasdaqGS:SHOPIT

Evaluating Shopify (SHOP) After Partnerships Restructuring AI Push And Legal Victory

Shopify (NasdaqGS:SHOP) is back in focus after restructuring its partnerships division, cutting roles tied to third party collaborators, while simultaneously emphasizing AI driven commerce projects and celebrating a major overturned patent verdict. See our latest analysis for Shopify. Those partnership layoffs and AI commerce pushes are unfolding against a weaker recent tape, with a 30 day share price return of 18.62% and a 90 day share price return of 20.27% showing fading near term...
NasdaqGS:AXON
NasdaqGS:AXONAerospace & Defense

Axon Enterprise (AXON) Valuation Revisited As AI Software Shift And Institutional Demand Gain Traction

Axon Enterprise (AXON) is back in focus as investors weigh its shift toward AI-powered software and services in the context of strong recurring revenue, institutional buying, and positive earnings and sales expectations. See our latest analysis for Axon Enterprise. Axon’s latest AI and software moves come after a mixed stretch for the share price, with a 3.72% 1 month share price return but a 16.69% 3 month share price decline. The 3 year total shareholder return of roughly 3x still points to...